Revlimid
Showing 576 - 598 of 598
Relapsed or Refractory Multiple Myeloma Trial in Germany (Lenalidomide, dexamethasone)
Completed
- Relapsed or Refractory Multiple Myeloma
-
Berlin, Germany
- +47 more
Sep 26, 2011
Non Hodgkin Lymphoma, Follicular Lymphoma Trial in Italy (LR-CHOP21)
Unknown status
- Non Hodgkin Lymphoma
- Follicular Lymphoma
-
Alessandria, Italy
- +17 more
Oct 12, 2011
MDS, Thrombocytopenia Trial (AMG 531, Placebo)
Completed
- Myelodysplastic Syndromes
- Thrombocytopenia
- AMG 531
- Placebo
- (no location specified)
Jan 20, 2011
MDS Trial in Worldwide (Lenalidomide 5 mg, Lenalidomide 10 mg, Placebo)
Completed
- Myelodysplastic Syndromes
- Lenalidomide 5 mg
- +2 more
-
Brugge, Belgium
- +37 more
Apr 12, 2011
Multiple Myeloma Trial in Leipzig (Lenalidomide, Bendamustine, Prednisone)
Unknown status
- Multiple Myeloma
- Lenalidomide, Bendamustine, Prednisone
-
Leipzig, GermanyUniversity of Leipzig
Aug 11, 2011
Chronic Lymphocytic Leukemia, CLL, Untreated Trial in United States (Lenalidomide and Rituximab)
Unknown status
- Chronic Lymphocytic Leukemia
- +5 more
- Lenalidomide and Rituximab
-
La Jolla, California
- +4 more
Sep 8, 2010
POEMS Syndrome Trial in Rozzano (Lenalidomide and dexamethasone)
Unknown status
- POEMS Syndrome
- Lenalidomide and dexamethasone
-
Rozzano, Milano, ItalyIstituto Clinco Humanitas
Sep 1, 2010
Multiple Myeloma Trial in Little Rock (CC-5013 (Revlimid™), bortezomib)
Completed
- Multiple Myeloma
- CC-5013 (Revlimid™)
- bortezomib
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences/MIRT
Jul 1, 2010
Solid Tumor Trial in Cleveland (docetaxel, lenalidomide)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
-
Cleveland, OhioIreland Cancer Center at University Hosptials Case Medical Cente
Jun 10, 2010
Solid Tumors Trial in Innsbruck (Lenalidomide, Cetuximab)
Unknown status
- Solid Tumors
-
Innsbruck, Tyrol, AustriaMedical University of Innsbruck, Department for Internal Medicin
Jul 19, 2010
Relapse, Refractory Multiple Myeloma Trial in Wuerzburg (Revlimid)
Completed
- Relapse
- Refractory Multiple Myeloma
- Revlimid
-
Wuerzburg, Bavaria, GermanyDept. of Internal Medicine II, University of Wuerzburg
Aug 3, 2009
Diffuse Large B-cell Lymphoma Trial in Australia, Canada, United States (CC-5013 (lenalidomide), dexamethasone)
Terminated
- Diffuse Large B-cell Lymphoma
- CC-5013 (lenalidomide)
- dexamethasone
-
Glendale, Arizona
- +23 more
Aug 27, 2009
Multiple Myeloma Trial in Canada, United States (lenalidomide, dexamethasone)
Completed
- Multiple Myeloma
-
Scottsdale, Arizona
- +68 more
Mar 10, 2010
Radiculopathy Trial in United States (Lenalidomide (CC-5013))
Completed
- Radiculopathy
- Lenalidomide (CC-5013)
-
Phoenix, Arizona
- +22 more
Sep 22, 2009
Complex Regional Pain Syndrome (RSD) Trial in United States (Lenalidomide)
Completed
- Complex Regional Pain Syndrome (RSD)
-
La Jolla, California
- +5 more
Dec 28, 2007
Multiple Myeloma Trial in Italy (Revlimid (CC-5013))
Completed
- Multiple Myeloma
- Revlimid (CC-5013)
-
San Giovanni Rotondo, Foggia, Italy
- +8 more
Nov 29, 2006
Ovarian Cancer Trial in United States (CC-5013, liposomal doxorubicin)
Terminated
- Ovarian Cancer
- CC-5013
- liposomal doxorubicin
-
San Francisco, California
- +4 more
Apr 10, 2006